This is a Firm Fixed Price Delivery Order awarded to Index Analytics LLC, an 8(a) certified small disadvantaged business, by the Food and Drug Administration (FDA) under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC). The contract is for MEDDRA Based Adverse Event Diagnostics (MAED) Maintenance, Support, and Enhancement Services, with a ceiling value of $1,155,079.19 and a period of performance ending on September 11, 2025. Index Analytics, a minority-owned limited liability company based in Catonsville, Maryland, specializes in providing IT solutions and services to federal health agencies within the Department of Health and Human Services (HHS). This contract supports the FDA's healthcare quality initiatives by leveraging Index Analytics' expertise in areas such as data management, business intelligence, and artificial intelligence/machine learning.
Generated 2/6/25, 9:09 AM